Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Business Intelligence & OLAP -- Ignore unavailable to you. Want to Upgrade?

To: Thomas DeGagne who wrote (42)	3/16/2001 1:42:06 PM
From: Thomas DeGagne	Respond to of 144

Another Sagent press release, this one concerning their refinancing. Sagent appears to be making the right moves to emerge from this time of volitillity as a player in the BI/AA/OLAP market. I havent been filled yet on my Sagent order, but i did pick up a number of DVIN shares. Devine is trading well below their cash on hand and has the strength and experienced management to be a new EIP player. Sagent Raises $16.6 Million Through Private Placement Straight Equity Investment Led by Zesiger Capital biz.yahoo.com MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Feb. 20, 2001--Sagent (Nasdaq:SGNT - news), a leading provider of Business Intelligence solutions, today announced that the company has completed an agreement for a $16.6 million private placement of its common stock with a select group of institutional investors led by Zesiger Capital of New York. ``During this era of dot-com fallout in Silicon Valley and ultra-conservative investing, this equity infusion is an endorsement of our new management team, core technologies, business strategy and long-term potential,'' said Ben Barnes, president and CEO, Sagent. A new strategic partner, as well as several other new institutional investment funds, including the Special Situation Funds, also of New York, also backed the private placement of approximately 5.7 million shares. Under the terms of the agreement, funding will be received within five business days. ``A prestigious group of investors is funding the capital resources we need to execute our new plans, and we are pleased to have them participate,'' Barnes said. ``Additionally, this investor group is financing Sagent through the purchase of common stock--terms that we believe are favorable to Sagent.''